Attenuating smac mimetic compound 3-induced NF-κB activation by luteolin leads to synergistic cytotoxicity in cancer cells

Journal of Cellular Biochemistry

Volumn 108, Issue 5, 2009, Pages 1125-1131

  Bai, Lang ^a   Chen, Wenjie ^a   Wang, Xia ^b   Ju, Wei ^a   Xu, Shanling ^a   Lin, Yong ^a  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Apoptosis; Cytotoxicity; Luteolin; NF B; SMAC mimetic

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUTEOLIN; SMAC MIMETIC COMPOUND 3; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BRONCHUS MUCOSA; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; DRUG SENSITIZATION; EPITHELIUM CELL; HEPATOMA CELL; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BRONCHI; CELL LINE, TUMOR; DRUG SYNERGISM; EPITHELIAL CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; LUNG NEOPLASMS; LUTEOLIN; MITOCHONDRIAL PROTEINS; MOLECULAR MIMICRY; NF-KAPPA B; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTORS;

EID: 72449169691     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22346     Document Type: Article

References (32)

1. Aggarwal BB. 2003. Signalling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol 3:745-756. (Pubitemid 41070815)
2. Bai L, Chen W, Wang X, Tang H, Lin Y. 2009. IKK{beta}-mediated nuclear factor-{kappa}B activation attenuates smac mimetic-induced apoptosis in cancer cells. Mol Cancer Ther 8:1636-1645.
3. Balkwill F. 2009. Tumour necrosis factor and cancer. Nat Rev Cancer 9:361-371.
4. Bank A, Wang P, Du C, Yu J, Zhang L. 2008. SMAC mimetics sensitize nonsteroidal anti-inflammatory drug-induced apoptosis by promoting caspase-3-mediated cytochrome c release. Cancer Res 68:276-284.
5. Bertrand MJ, Milutinovic S, Dickson KM, Ho WC, Boudreault A, Durkin J, Gillard JW, Jaquith JB, Morris SJ, Barker PA. 2008. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol Cell 30:689-700. (Pubitemid 351818251)
6. Chai J, Du C, Wu JW, Kyin S, Wang X, Shi Y. 2000. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 406:855-862. (Pubitemid 30664254)
7. Chen W, Wang X, Zhuang J, Zhang L, Lin Y. 2007. Induction of death receptor 5 and suppression of survivin contribute to sensitization of TRAIL-induced cytotoxicity by quercetin in non-small cell lung cancer cells. Carcinogenesis 28:2114-2121. (Pubitemid 47543370)
8. Du C, Fang M, Li Y, Li L, Wang X. 2000. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102:33-42.
9. Hanahan D, Weinberg RA. 2000. The hallmarks of cancer. Cell 100:57-70.
10. Ju W, Wang X, Shi H, Chen W, Belinsky SA, Lin Y. 2007. A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-kappaB pathway and sensitization of apoptosis in lung cancer cells. Mol Pharmacol 71:1381-1388. (Pubitemid 46658691)
11. Karin M. 2008. The IkappaB kinase - A bridge between inflammation and cancer. Cell Res 18:334-342. (Pubitemid 351333897)
12. Leung HW, Wu CH, Lin CH, Lee HZ. 2005. Luteolin induced DNA damage leading to human lung squamous carcinoma CH27 cell apoptosis. Eur J Pharmacol 508:77-83. (Pubitemid 40169904)
13. Lin Y, Devin A, Rodriguez Y, Liu ZG. 1999. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev 13:2514-2526. (Pubitemid 29489643)
14. Lin Y, Choksi S, Shen HM, Yang QF, Hur GM, Kim YS, Tran JH, Nedospasov SA, Liu ZG. 2004. Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation. J Biol Chem 279:10822-10828. (Pubitemid 38372695)
15. Lin Y, Yang Q, Wang X, Liu ZG. 2006. The essential role of the death domain kinase receptor-interacting protein in insulin growth factor-I-induced c-Jun N-terminal kinase activation. J Biol Chem 281:23525-23532. (Pubitemid 44274127)
16. Lin Y, Shi R, Wang X, Shen HM. 2008. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets 8:634-646.
17. Lopez-Lazaro M. 2009. Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem 9:31-59.
18. Lu J, Bai L, Sun H, Nikolovska-Coleska Z, McEachern D, Qiu S, Miller RS, Yi H, Shangary S, Sun Y, Meagher JL, Stuckey JA, Wang S. 2008. SM-164: A novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1/2 and XIAP. Cancer Res 68:9384-9393.
19. Mabuchi S, Ohmichi M, Nishio Y, Hayasaka T, Kimura A, Ohta T, Saito M, Kawagoe J, Takahashi K, Yada-Hashimoto N, Sakata M, Motoyama T, Kurachi H, Tasaka K, Murata Y. 2004. Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J Biol Chem 279:23477-23485. (Pubitemid 38685659)
20. Maschek G, Savaraj N, Priebe W, Braunschweiger P, Hamilton K, Tidmarsh GF, De Young LR, Lampidis TJ. 2004. 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res 64:31-34. (Pubitemid 38114078)
21. Petersen SL, Wang L, Yalcin-Chin A, Li L, Peyton M, Minna J, Harran P, Wang X. 2007. Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 12:445-456. (Pubitemid 350064365)
22. Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, Pollack J, Peyton M, Zou Y, Kurie JM, Dimaio JM, Milchgrub S, Smith AL, Souza RF, Gilbey L, Zhang X, Gandia K, Vaughan MB, Wright WE, Gazdar AF, Shay JW, Minna JD. 2004. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 64:9027-9034. (Pubitemid 39665513)
23. Seelinger G, Merfort I, Wolfle U, Schempp CM. 2008. Anti-carcinogenic effects of the flavonoid luteolin. Molecules 13:2628-2651.
24. Shi RX, Ong CN, Shen HM. 2004. Luteolin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells. Oncogene 23:7712-7721. (Pubitemid 39424929)
25. Varfolomeev E, Blankenship JW, Wayson SM, Fedorova AV, Kayagaki N, Garg P, Zobel K, Dynek JN, Elliott LO, Wallweber HJ, Flygare JA, Fairbrother WJ, Deshayes K, Dixit VM, Vucic D. 2007. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 131:669-681. (Pubitemid 350087204)
26. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ, Vaux DL. 2000. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102:43-53.
27. Vince JE, Wong WW, Khan N, Feltham R, Chau D, Ahmed AU, Benetatos CA, Chunduru SK, Condon SM, McKinlay M, Brink R, Leverkus M, Tergaonkar V, Schneider P, Callus BA, Koentgen F, Vaux DL, Silke J. 2007. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 131:682-693. (Pubitemid 350103599)
28. Wang X, Lin Y. 2008. Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin 29:1275-1288.
29. Wang X, Ju W, Renouard J, Aden J, Belinsky SA, Lin Y. 2006. 17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear factor-kappaB pathway. Cancer Res 66:1089-1095. (Pubitemid 43165977)
30. Wang X, Chen W, Lin Y. 2007. Sensitization of TNF-induced cytotoxicity in lung cancer cells by concurrent suppression of the NF-kappaB and Akt pathways. Biochem Biophys Res Commun 355:807-812. (Pubitemid 46330225)
31. Wang L, Du F, Wang X. 2008. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 133:693-703. (Pubitemid 351636305)
32. Wu H, Tschopp J, Lin SC. 2007. Smac mimetics and TNFalpha: A dangerous liaison? Cell 131:655-658.